GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ubiquitech Software Corp (OTCPK:UBQU) » Definitions » 10-Year RORE %

Ubiquitech Software (Ubiquitech Software) 10-Year RORE % : 0.00% (As of Aug. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Ubiquitech Software 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Ubiquitech Software does not have enough data to calculate 10-Year RORE %.


Ubiquitech Software 10-Year RORE % Historical Data

The historical data trend for Ubiquitech Software's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ubiquitech Software 10-Year RORE % Chart

Ubiquitech Software Annual Data
Trend Aug08
10-Year RORE %
-

Ubiquitech Software Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug22 Aug23
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ubiquitech Software's 10-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Ubiquitech Software's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ubiquitech Software's 10-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ubiquitech Software's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Ubiquitech Software's 10-Year RORE % falls into.



Ubiquitech Software 10-Year RORE % Calculation

Ubiquitech Software's 10-Year RORE % for the quarter that ended in Aug. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Aug. 2023 and 10-year before.


Ubiquitech Software  (OTCPK:UBQU) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Ubiquitech Software 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Ubiquitech Software's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ubiquitech Software (Ubiquitech Software) Business Description

Traded in Other Exchanges
N/A
Address
3570 East 12th Avenue, Denver, CO, USA, 80206
Ubiquitech Software Corp is a United States-based multi-media, multi-faceted company. It is engaged in utilizing global internet marketing, direct response television, radio, and traditional marketing to drive traffic to the new industries. The company also focuses on developing Cannabidiol (CBD) Hemp derived products. It owns the proprietary CBD brand CannazALL. The company offers the products through its internally designed and operated web portal www.cannazall.com.
Executives
Young Yuen director, 10 percent owner, officer: CEO/Pres/Secretary/Treasurer 7435 S. EASTERN AVENUE, SUITE 5, LAS VEGAS NV 89123